These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 2167274
1. Spin-labelling studies of the interaction of 9-amino-1,2,3,4-tetrahydroacridine (THA), a proposed drug for the treatment of Alzheimer's disease, with erythrocyte membranes. Butterfield DA, Palmieri DA. Free Radic Res Commun; 1990; 9(3-6):361-6. PubMed ID: 2167274 [Abstract] [Full Text] [Related]
2. Effects of 9-amino-1,2,3,4-tetrahydroacridine (THA), a potential drug for treatment of Alzheimer's disease, on the physical state of human erythrocyte membranes. Palmieri DA, Butterfield DA. Prog Clin Biol Res; 1989; 292():419-24. PubMed ID: 2726917 [No Abstract] [Full Text] [Related]
5. Morphological alterations in erythrocyte membranes induced by 9-amino-1,2,3,4-tetrahydroacridine and 9-aminoacridine. Palmieri DA, Jacob RJ, Butterfield DA. Biochem Biophys Res Commun; 1989 Sep 29; 163(3):1351-5. PubMed ID: 2783139 [Abstract] [Full Text] [Related]
10. ESR studies of the erythrocyte membrane skeletal protein network: influence of the state of aggregation of spectrin on the physical state of membrane proteins, bilayer lipids, and cell surface carbohydrates. Farmer BT, Harmon TM, Butterfield DA. Biochim Biophys Acta; 1985 Dec 19; 821(3):420-30. PubMed ID: 3000446 [Abstract] [Full Text] [Related]
11. Inhibitory effect of 9-amino-1,2,3,4-tetrahydroacridine (THA) on the potassium current of rabbit sinoatrial node. Kotake H, Hisatome I, Matsuoka S, Miyakoda H, Hasegawa J, Mashiba H. Cardiovasc Res; 1990 Jan 19; 24(1):42-6. PubMed ID: 2328513 [Abstract] [Full Text] [Related]
12. Inhibition of rat brain histamine-N-methyltransferase by 9-amino-1,2,3,4-tetrahydroacridine (THA). Cumming P, Reiner PB, Vincent SR. Biochem Pharmacol; 1990 Sep 15; 40(6):1345-50. PubMed ID: 2403387 [Abstract] [Full Text] [Related]
13. Multiple actions of THA on cholinergic neurotransmission in Alzheimer brains. Nordberg A, Nilsson-Håkansson L, Adem A, Lai Z, Winblad B. Prog Clin Biol Res; 1989 Sep 15; 317():1169-78. PubMed ID: 2557636 [Abstract] [Full Text] [Related]
14. Interaction of tacrine and velnacrine with neocortical synaptosomal membranes: relevance to Alzheimer's disease. Butterfield DA, Hensley K, Hall N, Umhauer S, Carney J. Neurochem Res; 1993 Sep 15; 18(9):989-94. PubMed ID: 8232727 [Abstract] [Full Text] [Related]
15. Changes in cytosolic free calcium with 1,2,3,4-tetrahydro-5-aminoacridine, 4-aminopyridine and 3,4-diaminopyridine. Gibson GE, Manger T. Biochem Pharmacol; 1988 Nov 01; 37(21):4191-6. PubMed ID: 2847755 [Abstract] [Full Text] [Related]
16. Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease. Drukarch B, Leysen JE, Stoof JC. Life Sci; 1988 Nov 01; 42(9):1011-7. PubMed ID: 2893967 [Abstract] [Full Text] [Related]
20. Strong interactions between a spin-labeled cholesterol analog and erythrocyte proteins in the human erythrocyte membrane. Seigneuret M, Favre E, Morrot G, Devaux PF. Biochim Biophys Acta; 1985 Mar 14; 813(2):174-82. PubMed ID: 2982401 [Abstract] [Full Text] [Related] Page: [Next] [New Search]